CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
17 12 2021
Historique:
received: 23 06 2021
revised: 10 07 2021
accepted: 21 07 2021
pubmed: 28 7 2021
medline: 8 4 2022
entrez: 27 7 2021
Statut: ppublish

Résumé

Alternative splicing has emerged as a fundamental mechanism for the spatiotemporal control of development. A better understanding of how this mechanism is regulated has the potential not only to elucidate fundamental biological principles, but also to decipher pathological mechanisms implicated in diseases where normal splicing networks are misregulated. Here, we took advantage of human pluripotent stem cells to decipher during human myogenesis the role of muscleblind-like (MBNL) proteins, a family of tissue-specific splicing regulators whose loss of function is associated with myotonic dystrophy type 1 (DM1), an inherited neuromuscular disease. Thanks to the CRISPR/Cas9 technology, we generated human-induced pluripotent stem cells (hiPSCs) depleted in MBNL proteins and evaluated the consequences of their losses on the generation of skeletal muscle cells. Our results suggested that MBNL proteins are required for the late myogenic maturation. In addition, loss of MBNL1 and MBNL2 recapitulated the main features of DM1 observed in hiPSC-derived skeletal muscle cells. Comparative transcriptomic analyses also revealed the muscle-related processes regulated by these proteins that are commonly misregulated in DM1. Together, our study reveals the temporal requirement of MBNL proteins in human myogenesis and should facilitate the identification of new therapeutic strategies capable to cope with the loss of function of these MBNL proteins.

Identifiants

pubmed: 34312665
pii: 6328616
doi: 10.1093/hmg/ddab218
pmc: PMC8682758
doi:

Substances chimiques

RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-56

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

J Neuromuscul Dis. 2020;7(4):395-405
pubmed: 32538862
Am J Pathol. 2009 Jan;174(1):216-27
pubmed: 19095965
Curr Opin Genet Dev. 2011 Aug;21(4):380-7
pubmed: 21514141
Stem Cells Transl Med. 2016 Sep;5(9):1145-61
pubmed: 27217344
Nucleic Acids Res. 2018 Jul 2;46(W1):W242-W245
pubmed: 29762716
Cell. 2009 Feb 20;136(4):777-93
pubmed: 19239895
iScience. 2019 Jan 25;11:258-271
pubmed: 30639849
Hum Mol Genet. 2006 Jul 1;15(13):2087-97
pubmed: 16717059
Sci Rep. 2016 Aug 03;6:30999
pubmed: 27484195
Mol Cell. 2014 Oct 23;56(2):311-322
pubmed: 25263597
Nat Commun. 2015 May 28;6:7205
pubmed: 26018658
Skelet Muscle. 2018 Jan 31;8(1):3
pubmed: 29386054
Nat Commun. 2013;4:2480
pubmed: 24048253
Differentiation. 2008 Mar;76(3):299-309
pubmed: 17697127
Int J Biochem Cell Biol. 2019 May;110:29-49
pubmed: 30818081
Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Semin Cell Dev Biol. 2020 Aug;104:65-80
pubmed: 32070639
Sci Rep. 2017 Feb 13;7:42522
pubmed: 28211918
Dis Model Mech. 2017 Apr 1;10(4):487-497
pubmed: 28188264
Stem Cell Res. 2018 Oct;32:61-64
pubmed: 30216892
Nucleic Acids Res. 2014;42(17):10873-87
pubmed: 25183524
Cell Rep. 2015 Aug 18;12(7):1159-68
pubmed: 26257173
Science. 2012 Dec 21;338(6114):1593-9
pubmed: 23258891
Mol Cell Biol. 2019 Oct 11;39(21):
pubmed: 31383751
Cell. 1992 Apr 17;69(2):385
pubmed: 1568252
Hum Mol Genet. 2002 Apr 1;11(7):805-14
pubmed: 11929853
EMBO J. 2006 Sep 20;25(18):4271-83
pubmed: 16946708
Development. 2017 Jun 15;144(12):2104-2122
pubmed: 28634270
Genome Res. 2014 Jun;24(6):1020-7
pubmed: 24696462
iScience. 2021 Jun 24;24(7):102767
pubmed: 34278269
Cell Rep. 2017 Oct 31;21(5):1240-1252
pubmed: 29091763
Ann Neurol. 2013 Dec;74(6):862-72
pubmed: 23929620
PLoS One. 2019 Oct 23;14(10):e0224206
pubmed: 31644553
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13307-133310
pubmed: 19622741
Hum Mol Genet. 2019 Apr 15;28(8):1312-1321
pubmed: 30561649
Hum Mol Genet. 2009 Apr 15;18(8):1471-81
pubmed: 19223393
J Cell Sci. 2015 Feb 15;128(4):631-7
pubmed: 25609712
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Muscle Nerve. 2007 Aug;36(2):251-7
pubmed: 17487865
Hum Mol Genet. 2010 Jun 1;19(11):2268-83
pubmed: 20233748
Science. 2003 Dec 12;302(5652):1978-80
pubmed: 14671308
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20333-8
pubmed: 19075228
Cell Rep. 2018 Jul 3;24(1):197-208
pubmed: 29972780
EMBO J. 2000 Sep 1;19(17):4439-48
pubmed: 10970838
Cells. 2019 Nov 26;8(12):
pubmed: 31779280
Hum Mol Genet. 2015 Apr 15;24(8):2360-74
pubmed: 25575511
Cell. 2012 Aug 17;150(4):710-24
pubmed: 22901804
Genes Cells. 2011 Sep;16(9):961-72
pubmed: 21794030
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Dis Model Mech. 2018 Jul 18;11(7):
pubmed: 29898953
Nat Struct Mol Biol. 2010 Feb;17(2):187-93
pubmed: 20098426
Nat Biotechnol. 2015 Sep;33(9):962-9
pubmed: 26237517
Science. 1992 Mar 6;255(5049):1253-5
pubmed: 1546325
Genes Dev. 2017 Jun 1;31(11):1122-1133
pubmed: 28698297
Neuron. 2012 Aug 9;75(3):437-50
pubmed: 22884328
Hum Mol Genet. 2013 Sep 1;22(17):3547-58
pubmed: 23660517
Genome Res. 2015 Jun;25(6):858-71
pubmed: 25883322
EMBO Mol Med. 2013 Dec;5(12):1887-900
pubmed: 24293317
Nat Med. 2011 Jun;17(6):720-5
pubmed: 21623381

Auteurs

Antoine Mérien (A)

INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, 91100 Corbeil-Essonnes, France.

Julie Tahraoui-Bories (J)

INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, 91100 Corbeil-Essonnes, France.

Michel Cailleret (M)

INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, 91100 Corbeil-Essonnes, France.

Jean-Baptiste Dupont (JB)

INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, 91100 Corbeil-Essonnes, France.

Céline Leteur (C)

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France.

Jérôme Polentes (J)

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France.

Alexandre Carteron (A)

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France.

Hélène Polvèche (H)

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France.

Jean-Paul Concordet (JP)

INSERM U1154/CNRS UMR7196, MNHN TACGENE, 75005 Paris, France.

Christian Pinset (C)

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France.

Margot Jarrige (M)

CECS/AFM, I-STEM, 91100 Corbeil-Essonnes, France.

Denis Furling (D)

Sorbonne Université, INSERM, Association Institut de Myologie, Centre de recherche en myologie, 75013 Paris, France.

Cécile Martinat (C)

INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, 91100 Corbeil-Essonnes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH